Cargando…
Genomic signature of MTOR could be an immunogenicity marker in human colorectal cancer
BACKGROUND: The mTOR signaling pathway plays an important role in cancer. As a master regulator, the status of MTOR affects pathway activity and the efficacy of mTOR inhibitor therapy. However, little research has been performed to explore MTOR in colorectal cancer (CRC). METHODS: In this study, gen...
Autores principales: | Wang, Chenxing, Aikemu, Batuer, Shao, Yanfei, Zhang, Sen, Yang, Guang, Hong, Hiju, Huang, Ling, Jia, Hongtao, Yang, Xiao, Zheng, Minhua, Sun, Jing, Li, Jianwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327395/ https://www.ncbi.nlm.nih.gov/pubmed/35883111 http://dx.doi.org/10.1186/s12885-022-09901-w |
Ejemplares similares
-
An Original Ferroptosis-Related Gene Signature Effectively Predicts the Prognosis and Clinical Status for Colorectal Cancer Patients
por: Shao, Yanfei, et al.
Publicado: (2021) -
NDRG1 enhances the sensitivity of cetuximab by modulating EGFR trafficking in colorectal cancer
por: Yang, Guang, et al.
Publicado: (2021) -
NDRG1 regulates Filopodia-induced Colorectal Cancer invasiveness via modulating CDC42 activity
por: Aikemu, Batuer, et al.
Publicado: (2021) -
Comprehensive exploration of tumor immune microenvironment feature and therapeutic response in colorectal cancer based on a novel immune-related long non-coding RNA prognostic signature
por: Zhou, Xueliang, et al.
Publicado: (2022) -
Comprehensive Analysis of Ferroptosis-Related Markers for the Clinical and Biological Value in Gastric Cancer
por: Shao, Yanfei, et al.
Publicado: (2021)